Raising awareness about the importance of chickenpox vaccination in children
DOI:
https://doi.org/10.12775/JEHS.2023.19.01.012Keywords
varicella-complications, zoster, vaccinationsAbstract
Introduction: Varicella is an acute infectious disease caused by the Varicella zoster virus. It is among one of the most contagious infectious diseases. The main symptoms of the disease are an itchy, papular and vesicular rash on the trunk, face, scalp, extremities, mucous membranes. In addition, there is fever, malaise, headache and muscle aches, enlargement of lymph nodes. In most cases, varicella is mild, but 2-6% of patients may develop dangerous complications. The most common complications include bacterial skin infections, neurological symptoms and acute thrombocytopenia.
Aim: The purpose of this study is to present the severe and complicated course of varicella in a 12-month-old patient.
Results: On the day of admission, the patient presented symptoms of an exacerbation of the course of varicella. The main symptoms were smallpox eruptions, increasing fever track, and enlarged and painful lymph nodes. During his stay, the patient's condition indicated a severe course of varicella. It was complicated by infection of the skin, subcutaneous tissue and lymph nodes. In addition, tests showed Epstein-Barr virus (EBV) infection and positivity for cat scratch disease. He also developed zoster during his hospitalization. Throughout his stay in the hospital, many tests and consultations were carried out to clarify his symptoms. With appropriate treatment, the patient's condition improved and he was able to be discharged home after a 3-week hospitalization.
Conclusions: The presented case shows the severe course of varicella. Due to recommendations and the patient's too young age, he could not be vaccinated against VZV. In each patient, the course of the disease is unpredictable. Vaccination protects against severe symptoms, and also reduces the risk of developing zoster in the future. In addition, long-term immunity can be acquired through vaccination.
References
Gershon, A.A.; Breuer, J.; Cohen, J.I.; Cohrs, R.J.; Gershon, M.D.; Gilden, D.; Grose, C.; Hambleton, S.; Kennedy, P.G.E.; Oxman, M.N.; et al. 2015, Varicella zoster virus infection. Nat. Rev. Dis. Prim. 1, 1–18
Kennedy, P.G.E.; Gershon, A.A., 2018, Clinical features of Varicella-Zoster virus infection of the nervous system. Viruses 10, 609
Blair, R. J. (2019). Varicella Zoster Virus. Pediatrics in Review, 40(7), 375–377
Varicella-Zoster Virus Infections. American Academy of Pediatrics. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2015:846–860)
5. COMMUNICATION OF THE MAIN SANITARY INSPECTOR of October 26, 2020 on the Immunization Program for 2021; access June 26, 2023 http://dziennikmz.mz.gov.pl/api/DUM_MZ/2019/87/journal/5727
Marin M, Seward JF, Gershon AA. 25 Years of Varicella Vaccination in the United States. J Infect Dis 2022;226(4):375-9
Variciella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec 2014;89:265-87
J Bogusz, I Paradowska-Stankiewicz, Chickenpox in Poland in 2020; Epidemiological review 2022, 76(4): 568-573
Czarkowski MP, et al. Szczepienia ochronne w Polsce w 2020 r. Warszawa NIZP-PZH; GIS. 2021. Available from: http://wwwold.pzh.gov.pl/oldpage/epimeld/2020/Sz_2020.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Aleksandra Borkowska, Szymon Marosz, Karol Marosz, Zuzanna Chilimoniuk, Anna Sobstyl, Dominik Dudziński, Aleksandra Chałupnik, Katarzyna Krupska, Halina Piecewicz-Szczęsna
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 489
Number of citations: 0